Please try another search
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women’s health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company has a strategic partnership with Orbicular Pharmaceutical Technologies Private Limited to develop, manufacture, and commercialize nasal sprays. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Name | Age | Since | Title |
---|---|---|---|
Aditya Puri | 70 | 2021 | Non-Executive Chairman |
Mahadevan Narayanamoni | - | - | Non-Executive Director |
Dennis Bastas | - | 2015 | Executive Chairman of Arrow Pharmaceuticals Pty Ltd |
Badree Komandur | 50 | 2010 | Group CFO, Executive Director of Finance & Executive Director |
Arun Kumar Pillai | - | 1990 | Founder, Executive Chairperson & MD |
B. Suresh | - | - | Member of Scientific Advisory Board |
Srinivasan Sridhar | 71 | 2012 | Independent Director |
Gopakumar Gopalan Nair | 81 | - | Member of Scientific Advisory Board |
Homi Rustam Khusrokhan | 78 | 2017 | Independent Director |
Elias David Neto | - | - | Member of Scientific Advisory Board |
S. P. Vyas | - | - | Member of Scientific Advisory Board |
C. M. Gupta | - | - | Member of Scientific Advisory Board |
Bharat Dhirajlal Shah | 75 | 2014 | Independent Director |
Kausalya Santhanam | 55 | 2019 | Independent Director |
Ameet P Hariani | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review